UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | M | P | R | S | T | V | W | Y | Z
Number of items: 103.

A

Abdel-Aziz, K; Solanky, B; Yiannakas, MC; Wheeler-Kingshot, CAM; Thompson, A; Ciccarelli, O; (2012) Spinal cord metabolic changes at onset of a relapse in relapsing remitting multiple sclerosis. In: Multiple Sclerosis Journal. (pp. 395 - ?).

Abdel-Aziz, K; Solanky, B; Yiannakas, MC; Wheeler-Kingshott, CAM; Thompson, AJ; Ciccarelli, O; (2012) Spinal cord metabolic changes at onset of a relapse in relapsing-remitting multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 155 - 156).

Abu Bakar, N; Chard, D; Matharu, MS; (2012) Bilateral paroxysmal cephalalgia: a novel indomethacin-responsive primary headache syndrome? Cephalalgia , 32 (13) 1005 - 1008. 10.1177/0333102412455705.

Altmann, DR; Button, T; Schmierer, K; Hunter, K; Tozer, D; Wheeler-Kingshott, C; ... Miller, DH; + view all (2012) Sample sizes for lesion magnetisation transfer ratio outcome measures in remyelination trials for multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL , 18 470 - 470.

Anderson, VM; Schott, JM; Bartlett, JW; Leung, KK; Miller, DH; Fox, NC; (2012) Gray matter atrophy rate as a marker of disease progression in AD. Neurobiol Aging , 33 (7) 1194 - 1202. 10.1016/j.neurobiolaging.2010.11.001.

Ascherio, A; Munger, K; Simon, C; Kappos, L; Polman, CH; Freedman, MS; ... Pohl, C; + view all (2012) Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 374 - 375).

B

Bar-Or, A; Arnold, DL; Gold, R; Fox, RJ; MacManus, DG; Yousry, T; ... Miller, DH; + view all (2012) Effects of oral BG-12 (Dimethyl Fumarate) on Magnetic Resonance Imaging (Mri) Outcomes in Relapsing-Remitting Multiple Sclerosis (Rrms): an Integrated Analysis of the Phase 3 Define and Confirm Studies. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 1836 - 1836).

Barkhof, F; Nagtegaal, G; Wattjes, MP; Polman, CH; Hulst, HE; Freedman, MS; ... Sandbrink, R; + view all (2012) Early therapy with IFNB-1b started at the first event suggestive of MS reduces the evolution of persistent T1 hypointensities on brain MRI. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 202 - 203).

Barkhof, F; Simon, JH; Fazekas, F; Rovaris, M; Kappos, L; de Stefano, N; ... Filippi, M; + view all (2012) MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. NATURE REVIEWS NEUROLOGY , 8 (1) 13 - 21. 10.1038/nrneurol.2011.190.

Bei, F; Smith, KJ; (2012) Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo. Neuropharmacology , 63 (3) 405 - 414. 10.1016/j.neuropharm.2012.04.019. Green and gold open access
file

Bible, E; Dell'Acqua, F; Solanky, B; Balducci, A; Crapo, PM; Badylak, SF; ... Modo, M; + view all (2012) Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials , 33 (10) 2858 - 2871. 10.1016/j.biomaterials.2011.12.033.

Bodini, B; Chard, D; Altmann, D; Tozer, D; Miller, DH; Thompson, AJ; ... Ciccarelli, O; + view all (2012) Does white matter damage predict later grey matter changes in early primary-progressive MS? In: MULTIPLE SCLEROSIS JOURNAL. (pp. 118 - 119).

Bonelli, S; Thompson, PJ; Yogarajah, M; Powell, R; Samson, R; Mcevoy, AW; ... Duncan, J; + view all (2012) IMAGING MEMORY IN TEMPORAL LOBE EPILEPSY: REORGANISATION OF MEMORY FUNCTION FOLLOWING ANTERIOR TEMPORAL LOBE RESECTION - RESULTS OF A LONGITUDINAL FMRI STUDY. In: EPILEPSIA. (pp. 13 - 13).

Bruno, SD; Cercignani, M; Wheeler-Kingshott, CAM; (2012) Neurodegenerative dementias: From MR Physics lab to assessment room. EUROPEAN PHYSICAL JOURNAL PLUS , 127 (11) , Article ARTN 139. 10.1140/epjp/i2012-12139-2.

C

Campbell, GR; Kraytsberg, Y; Krishnan, KJ; Ohno, N; Ziabreva, I; Reeve, A; ... Mahad, DJ; + view all (2012) Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis. ACTA NEUROPATHOLOGICA , 124 (2) 209 - 220. 10.1007/s00401-012-1001-9.

Chataway, J; Alsanousi, A; Chan, D; Macmanus, D; Hunter, K; Foster, J; ... Nicholas, R; + view all (2012) The MS-STAT trial: a randomised placebo-controlled phase II trial of high dose simvastatin in secondary progressive multiple sclerosis (SPMS). In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 87 - 87).

Chataway, J; Alsanousi, A; Chan, D; MacManus, D; Hunter, K; Foster, J; ... Nicholas, R; + view all (2012) The MS-STAT trial: high dose simvastatin demonstrates neuroprotection without immune-modulation in secondary progressive multiple sclerosis (SPMS) - a phase II trial. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 509 - 509).

Ciccarelli, O; Kwok, PP; Wottschel, V; Chard, D; Stromillo, ML; De Stefano, N; ... Alexander, DH; + view all (2012) Predicting clinical conversion to multiple sclerosis in patients with clinically isolated syndrome using machine learning techniques. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 30 - 31).

Colombo, E; Cordiglieri, C; Melli, G; Newcombe, J; Krumbholz, M; Parada, LF; ... Farina, C; + view all (2012) Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. JOURNAL OF EXPERIMENTAL MEDICINE , 209 (3) 521 - 535. 10.1084/jem.20110698.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; ... Chandran, S; + view all (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. LANCET NEUROLOGY , 11 (2) 150 - 156. 10.1016/S1474-4422(11)70305-2.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; ... Chandran, S; + view all (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol , 11 (2) 150 - 156. 10.1016/S1474-4422(11)70305-2.

Crehan, H; Hardy, J; Pocock, J; (2012) Microglia, Alzheimer's disease, and complement. Int J Alzheimers Dis , 2012 983640 - ?. 10.1155/2012/983640. Gold open access

Crehan, H; Holton, P; Wray, S; Pocock, J; Guerreiro, R; Hardy, J; (2012) Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology , 217 (2) 244 - 250. 10.1016/j.imbio.2011.07.017.

D

Dalton, CM; Bodini, B; Samson, RS; Battaglini, M; Fisniku, LK; Thompson, AJ; ... Chard, DT; + view all (2012) Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler , 18 (3) 322 - 328. 10.1177/1352458511420269.

De Vita, E; Mulhert, N; Atzori, M; Thomas, DL; Wheeler-Kingshott, CAM; Guerts, JJG; ... Ciccarelli, O; + view all (2012) Glutamate reduces in grey matter of MS patients and correlates with cognitive impairment. In: Proc. Intl. Soc. Magn. Reson. Med.

E

Edan, G; Kappos, L; Montalban, X; Polman, C; Freedman, M; Hartung, H; ... Pleimes, D; + view all (2012) Early Initiation of Interferon Beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the BENEFIT Extension Study. In: NEUROLOGY.

Edan, G; Kappos, L; Montalban, X; Polman, C; Freedman, MS; Hartung, HP; ... Pleimes, D; + view all (2012) Early Initiation of Interferon Beta-1b After a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the Benefit Extension Study. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 1835 - 1835).

F

Ferizi, U; Panagiotaki, E; Schneider, T; Wheeler-Kingshott, CAM; Alexander, DC; (2012) White Matter Models of In Vivo Diffusion MRI Human Brain Data: A Statistical Ranking. In: Proceeding of the 16th Conference on Medical Image Understanding and Analysis.

Filippi, M; Rocca, MA; Barkhof, F; Brueck, W; Chen, JT; Comi, G; ... Lassmann, H; + view all (2012) Association between pathological and MRI findings in multiple sclerosis. LANCET NEUROLOGY , 11 (4) 349 - 360.

Fox, R; Miller, D; Phillips, JT; Kita, M; Hutchinson, M; Havrdova, E; ... Dawson, K; + view all (2012) Clinical Efficacy of BG-12 in Relapsing-Remitting Multiple Sclerosis (RRMS): Data from the Phase 3 CONFIRM Study. In: NEUROLOGY.

Fox, RJ; Miller, DH; Phillips, JT; Hutchinson, M; Havrdova, E; Kita, M; ... Investigators, CONFIRMS; + view all (2012) Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis. NEW ENGLAND JOURNAL OF MEDICINE , 367 (12) 1087 - 1097. 10.1056/NEJMoa1206328.

Franklin, RJ; ffrench-Constant, C; Edgar, JM; Smith, KJ; (2012) Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol , 8 (11) 624 - 634. 10.1038/nrneurol.2012.200.

Freedman, MS; Metzig, C; Kappos, L; Polman, CH; Edan, G; Hartung, H-P; ... Pohl, C; + view all (2012) Predictive nature of IgM anti-alpha-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis. MULTIPLE SCLEROSIS JOURNAL , 18 (7) 966 - 973. 10.1177/1352458511432327.

Freund, P; Schneider, T; Nagy, Z; Hutton, C; Weiskopf, N; Friston, K; ... Thompson, AJ; + view all (2012) Degeneration of the injured cervical cord is associated with remote changes in corticospinal tract integrity and upper limb impairment. PLOS One , 7 (12) , Article e51729. 10.1371/journal.pone.0051729. Green and gold open access
file

Freund, P; Wheeler-Kingshott, CA; Nagy, Z; Gorgoraptis, N; Weiskopf, N; Friston, K; ... Hutton, C; + view all (2012) Axonal integrity predicts cortical reorganisation following cervical injury. Journal of Neurology, Neurosurgery & Psychiatry , 83 (6) 629 -637. 10.1136/jnnp-2011-301875. Green and gold open access
file

G

Giorgio, A; Battaglini, M; Rocca, MA; De Leucio, A; Absinta, M; Barkhof, F; ... De Stefano, N; + view all (2012) Spatial mapping of brain lesions in clinically isolated syndrome with short-term conversion to multiple sclerosis. In: JOURNAL OF NEUROLOGY. (pp. S48 - S48).

Gold, R; Miller, DH; Phillips, JT; Arnold, DL; Selmaj, K; Yang, M; ... Fox, RJ; + view all (2012) Clinical efficacy of BG-12 in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 48 - 49).

Gutiérrez-Galve, L; Bruno, S; Wheeler-Kingshott, CA; Summers, M; Cipolotti, L; Ron, MA; (2012) IQ and the fronto-temporal cortex in bipolar disorder. J Int Neuropsychol Soc , 18 (2) 370 - 374. 10.1017/S1355617711001706.

H

Havrdova, E; Fox, RJ; Miller, D; Phillips, JT; Kita, M; Hutchinson, M; ... Dawson, KT; + view all (2012) Clinical outcomes with BG-12 treatment in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a multicentre, randomised, placebo-controlled, phase 3 study. In: JOURNAL OF NEUROLOGY. (pp. S36 - S36).

Havrdova, E; Miller, D; Fox, RJ; Phillips, JT; Kita, M; Hutchinson, M; ... Dawson, KT; + view all (2012) Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 87 - 87).

Havrdova, E; Phillips, JT; Fox, RJ; Miller, D; Kita, M; Hutchinson, M; ... Dawson, KT; + view all (2012) Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study. In: JOURNAL OF NEUROLOGY. (pp. S105 - S105).

Hayton, T; Furby, J; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; ... Kapoor, R; + view all (2012) Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis. J Neurol , 259 (2) 237 - 245. 10.1007/s00415-011-6151-5.

Hayton, T; Furby, J; Smith, KJ; Altmann, DR; Brenner, R; Chataway, J; ... Kapoor, R; + view all (2012) Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine. J Neurol , 259 (3) 505 - 514. 10.1007/s00415-011-6212-9.

Hutchinson, M; Fox, RJ; Miller, D; Phillips, JT; Kita, M; Havrdova, E; ... Dawson, KT; + view all (2012) Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis) study. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 355 - 355).

Hutchinson, M; Fox, RJ; Miller, D; Phillips, JT; Kita, M; Havrdova, E; ... Dawson, KT; + view all (2012) Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study. In: JOURNAL OF NEUROLOGY. (pp. S105 - S106).

I

Iravani, MM; Sadeghian, M; Leung, CC; Jenner, P; Rose, S; (2012) Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor. Neurosci Lett , 510 (2) 138 - 142. 10.1016/j.neulet.2012.01.022.

J

Jebelli, JD; Hooper, C; Garden, GA; Pocock, JM; (2012) Emerging roles of p53 in glial cell function in health and disease. Glia , 60 (4) 515 - 525. 10.1002/glia.22268.

K

Kappos, L; Gold, R; Miller, DH; MacManus, DG; Havrdova, E; Limmroth, V; ... O'Neill, GN; + view all (2012) Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study. Mult Scler , 18 (3) 314 - 321. 10.1177/1352458511421054.

Kearney, H; Miszkiel, K; Yiannakas, M; Ciccarelli, O; Miller, D; (2012) Improved Radiological Localization of Spinal Cord Lesions in Multiple Sclerosis. In: NEUROLOGY.

Kearney, H; Yiannakas, MC; Abdel-Aziz, K; Wheeler-Kingshott, CAM; Ciccarelli, O; Miller, DH; (2012) Improving the detection of spinal cord atrophy in multiple sclerosis: evaluation of methodologies at six-month follow-up. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 155 - 155).

Kwok, PP; Alexander, DC; Ciccarelli, O; Chard, DT; Miller, DH; (2012) Predicting clinically definite multiple sclerosis from onset using SVM. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). (pp. 116 - 123).

M

Marina, N; Sajic, M; Bull, ND; Hyatt, AJ; Berry, D; Smith, KJ; Martin, KR; (2012) Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension. Exp Eye Res , 104 1 - 6. 10.1016/j.exer.2012.09.002.

Mead, E.L.; (2012) Regulation of the microglial NADPH oxidase by neurotransmitters: implications for microglial – neuronal interactions. Doctoral thesis, UCL (University College London). Green open access
file

Mead, EL; Mosley, A; Eaton, S; Dobson, L; Heales, SJ; Pocock, JM; (2012) Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J Neurochem , 121 (2) 287 - 301. 10.1111/j.1471-4159.2012.07659.x.

Miller, D; (2012) MR and OCT markers. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 35 - 36).

Miller, D; Fox, R; Phillips, JT; Kita, M; Hutchinson, M; Havrdova, E; ... Dawson, K; + view all (2012) Effects of BG-12 on Magnetic Resonance Imaging (MRI) Endpoints in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Data From the Phase 3 CONFIRM Study. In: NEUROLOGY.

Miller, D; Fox, RJ; Phillips, JT; Kita, M; Hutchinson, M; Havrdova, E; ... Dawson, KT; + view all (2012) Effects of BG-12 on magnetic resonance imaging outcomes in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a randomized, placebo-controlled, phase 3 study. In: JOURNAL OF NEUROLOGY. (pp. S36 - S37).

Miller, DH; (2012) In assessing multiple sclerosis disease activity patient report measures are a waste of time: cut to the MRI scan!--Yes. Mult Scler , 18 (3) 264 - 265. 10.1177/1352458512438118.

Miller, DH; Altmann, DR; Chard, DT; (2012) Advances in imaging to support the development of novel therapies for multiple sclerosis. Clin Pharmacol Ther , 91 (4) 621 - 634. 10.1038/clpt.2011.349.

Miller, DH; Chard, DT; Ciccarelli, O; (2012) Clinically isolated syndromes. Lancet Neurol , 11 (2) 157 - 169. 10.1016/S1474-4422(11)70274-5.

Miller, DH; Gold, R; Fox, RJ; MacManus, D; Yousry, T; Bar-Or, A; ... Arnold, DL; + view all (2012) Effects of BG-12 on magnetic resonance imaging outcomes in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 418 - 418).

Miller, DH; Hutchinson, M; Fox, RJ; Phillips, JT; Kita, M; Havrdova, E; ... Dawson, KT; + view all (2012) Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 189 - 190).

Miller, DH; Weber, T; Grove, R; Wardell, C; Horrigan, J; Graff, O; ... Montalban, X; + view all (2012) Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol , 11 (2) 131 - 139. 10.1016/S1474-4422(11)70299-X.

Montalban, X; Kappos, L; Freedman, MS; Hartung, H-P; Edan, G; Miller, DH; ... Pleimes, D; + view all (2012) Application of the revised version of the 2010 McDonald diagnostic criteria: retrospective comparison using the BEN-EFIT clinical study dataset. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 284 - 285).

Muhlert, N; Sethi, V; Ron, M; Cipolotti, L; Parker, G; Haroon, H; ... Chard, DT; + view all (2012) Impaired decision-making in MS and grey matter diffusion orientational complexity. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 11 - 12).

P

Paling, D; Petersen, E; Tozer, D; Wheeler-Kingshott, C; Kapoor, R; Miller, D; Golay, X; (2012) Alteration in cerebral haemodynamics in multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 156 - 156).

Paling, D; Solanky, B; Riemer, F; Wheeler-Kingshott, C; Golay, X; Kapoor, R; Miller, D; (2012) Regional changes in tissue sodium concentration in relapsing-remitting and secondary progressive MS. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 384 - 384).

Paling, D; Tozer, D; Wheeler-Kingshott, C; Kapoor, R; Miller, DH; Golay, X; (2012) Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. J Neurol Neurosurg Psychiatry , 83 (8) 785 - 792. 10.1136/jnnp-2012-302541.

Paling, D; Tozer, D; Wheeler-Kingshott, C; Kapoor, R; Miller, DH; Golay, X; (2012) Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content. J Neurol Neurosurg Psychiatry , 83 (8) 785 - 792. 10.1136/jnnp-2012-302541.

Panagiotaki, E; Schneider, T; Siow, B; Hall, MG; Lythgoe, MF; Alexander, DC; (2012) Compartment models of the diffusion MR signal in brain white matter: a taxonomy and comparison. Neuroimage , 59 (3) 2241 - 2254. 10.1016/j.neuroimage.2011.09.081.

Penner, I-K; Calabrese, P; Kappos, L; Stemper, B; Pleimes, D; Lanius, V; ... Montalbán, X; + view all (2012) Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Multiple Sclerosis , 18 (10) 1466 - 1471. 10.1177/1352458512442438.

Phillips, JT; Fox, R; Miller, D; Kita, M; Hutchinson, M; Havrdova, E; ... Dawson, K; + view all (2012) Safety and Tolerability of BG-12 in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Analyses From the CONFIRM Study. In: NEUROLOGY.

Piers, T.M.; (2012) Fibrin and fibrinogen pathways in microglia fibrinogen-induced signalling – implications for neurodegeneration. Doctoral thesis, UCL (University College London). Green open access
file

Polman, CH; Cree, B; Freedman, MS; Hartung, H-P; Holdbrook, F; Kappos, L; ... Wolinsky, JS; + view all (2012) Trial design and baseline data of the INFORMS (fingolimod in patients with primary progressive multiple sclerosis) study. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 437 - 438).

Popescu, V; Hoogstrate, WS; Verfaillie, SCJ; Sluimer, IC; van Schijndel, RA; Barkhof, F; ... Rovira, A; + view all (2012) Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis. NeuroImage , 61 (4) 1484 - 1494. 10.1016/j.neuroimage.2012.03.074.

R

Raftopoulos, RE; Hickman, S; Toosy, A; Wheeler-Kingshott, CA; Altmann, D; Schmierer, K; ... Kapoor, R; + view all (2012) A phase II double-blind, randomised, placebo-controlled trial of neuroprotection with phenytoin in acute optic neuritis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 442 - 443).

Rajgor, R; Muhlert, N; Lutti, A; Atzori, M; Weiskopf, N; Wheeler-Kingshott, CAM; ... Thomas, DL; + view all (2012) Generating synthetic DIR images using multi-parameter maps; application to lesion detection in MS. In: (Proceedings) ISMRM. (pp. 2549 - ?). Proc Intl Soc Mag Reson Med

Roggerone, S; Tourdias, T; Brochet, B; Molinier, S; Bocquet, J; Vukusic, S; ... Dousset, V; + view all (2012) Assessment of disease activity in multiple sclerosis phenotypes using a combined gadolinium and iron oxide nanoparticles MR contrast. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 398 - 398).

Ropele, S; Wattjes, M; Kilsdonk, ID; de Graaf, W; Langkammer, C; Frederiksen, JL; ... Fazekas, F; + view all (2012) R2*based iron mapping in multiple sclerosis: a multicentre study. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 165 - 166).

Roura, E; Schneider, T; Daga, P; Modat, M; Muhlert, N; Freixenet, J; ... Wheeler-Kingshott, CAM; + view all (2012) Multi-channel registration of FA and T1-weighted images to standard space: patients with multiple sclerosis. In: Proc Intl Soc Mag Reson Med. (pp. 825 - 825).

S

Sadeghian, M; Marinova-Mutafchieva, L; Broom, L; Davis, JB; Virley, D; Medhurst, AD; Dexter, DT; (2012) Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression. J Neuroimmunol , 246 (1-2) 69 - 77. 10.1016/j.jneuroim.2012.03.010.

Sadeghian, M; Mosely, A; Mastrolia, V; Mullali, G; Bowen, S; Sajic, M; ... Smith, K; + view all (2012) Mitochondrial fragmentation and loss of function at the onset of neurological deficit in a neuroinflammatory model of multiple sclerosis (MS) studied by in vivo imaging. In: JOURNAL OF NEUROIMMUNOLOGY. (pp. 124 - 125).

Sajic, M; Gregson, N; Linington, C; Hughes, RA; Smith, KJ; (2012) The role of CD8(+) T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein. Mult Scler , 18 (3) 286 - 298. 10.1177/1352458511424309.

Sajic, M; Hunt, DP; Lee, W; Compston, DA; Schweimer, JV; Gregson, NA; ... Smith, KJ; + view all (2012) Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. PLoS One , 7 (2) , Article e30708 . 10.1371/journal.pone.0030708. Green and gold open access
file

Samson, RS; Cardoso, MJ; Muhlert, N; Sethi, V; Wheeler-Kingshott, CAM; Ourselin, S; ... Chard, DT; + view all (2012) MTR analysis of inner and outer cortical bands in multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 383 - 384).

Schneider, T; Wheeler-Kingshott, CAM; Alexander, DC; (2012) Mapping the axon diameter index in the corpus callosum is clinically feasible. In: Proceedings of the International Society for Magnetic Resonance in Medicine (ISMRM 2012): 20th Annual Meeting and Exhibition.

Sethi, V; Yousry, T; Muhlert, N; Ron, M; Golay, X; Wheeler-Kingshott, C; ... Chard, D; + view all (2012) Classification by location of cortical grey matter lesions studied using phase sensitive inversion recovery. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 119 - 119).

Sethi, V; Yousry, T; Muhlert, N; Ron, M; Golay, X; Wheeler-Kingshott, C; ... Chard, D; + view all (2012) Improving the Detection of Grey Matter Lesions in MS Using MRI: A Comparison of Double Inversion Recovery and Phase Sensitive Inversion Recovery. In: NEUROLOGY.

Sethi, V; Yousry, T; Muhlert, N; Ron, M; Golay, X; Wheeler-Kingshott, C; ... Chard, D; + view all (2012) Morphology of cortical grey matter lesions - a possible diagnostic role? In: MULTIPLE SCLEROSIS JOURNAL. (pp. 345 - 346).

Sethi, V; Yousry, TA; Muhlert, N; Ron, M; Golay, X; Wheeler-Kingshott, C; ... Chard, DT; + view all (2012) Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry , 83 (9) 877 - 882. 10.1136/jnnp-2012-303023.

Solanky, BS; Abdel-Aziz, K; Yiannakas, M; Ciccarelli, O; Wheeler-Kingshott, CAM; (2012) Glutamate-glutamine detection using 1H MRS in the human cervical spinal cord at 3T. In: Proc Intl Soc Mag Reson Med. (pp. 620 - 620). Neurology

Stroman, PW; Bosma, RL; Kornelsen, J; Lawrence-Dewar, J; Wheeler-Kingshott, C; Cadotte, D; Fehlings, MG; (2012) Advanced MR imaging techniques and characterization of residual anatomy. Clin Neurol Neurosurg , 114 (5) 460 - 470. 10.1016/j.clineuro.2012.01.003.

T

Tourdias, T; Roggerone, S; Filippi, M; Kanagaki, M; Rovaris, M; Miller, DH; ... Dousset, V; + view all (2012) Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology , 264 (1) 225 - 233. 10.1148/radiol.12111416.

Tozer, DJ; Chard, DT; Bodini, B; Ciccarelli, O; Miller, DH; Thompson, AJ; Wheeler-Kingshott, CA; (2012) Linking white matter tracts to associated cortical grey matter: a tract extension methodology. Neuroimage , 59 (4) 3094 - 3102. 10.1016/j.neuroimage.2011.10.088.

V

van de Pavert, SHP; Muhlert, N; Sethi, V; Wheeler-Kingshott, CA; Thompson, AJ; Geurts, JJG; ... Ciccarelli, O; + view all (2012) Co-localisation of grey matter volume reduction and grey matter lesions in multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL. (pp. 344 - 344).

W

Wheeler-Kingshott, CA; (2012) Technology-driven progress. Funct Neurol , 27 (3) 129 - ?. Gold open access

Wheeler-Kingshott, CA; Ciccarelli, O; Schneider, T; Alexander, DC; Cercignani, M; (2012) A new approach to structural integrity assessment based on axial and radial diffusivities. Funct Neurol , 27 (2) 85 - 90. Gold open access

Y

Yiannakas, MC; Kearney, H; Ciccarelli, O; Miller, DH; Wheeler-Kingshott, CAM; (2012) Cervical cord lesion characterisation in multiple sclerosis (MS). In: (Proceedings) ISMRM. (pp. 829 - ?). Proc Intl Soc Mag Reson Med

Yiannakas, MC; Kearney, H; Samson, RS; Chard, DT; Ciccarelli, O; Miller, DH; Wheeler-Kingshott, CA; (2012) Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: a pilot study with application to magnetisation transfer measurements. Neuroimage , 63 (3) 1054 - 1059. 10.1016/j.neuroimage.2012.07.048.

Z

Zhang, H; Schneider, T; wheeler-kingshott, C; Alexander, DC; (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. In: Proceedings for the Organization of Human Brain Mapping.

Zhang, H; Schneider, T; Wheeler-Kingshott, CA; Alexander, DC; (2012) NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain. In: NEUROIMAGE. (pp. 1000 - 1016).

Zhang, H; Schneider, T; Wheeler-Kingshott, CA; Alexander, DC; (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage , 61 (4) 1000 - 1016. 10.1016/j.neuroimage.2012.03.072.

Zhang, H; Schneider, T; Wheeler-Kingshott, CA; Alexander, DC; (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage , 61 (4) 1000 - 1016. 10.1016/j.neuroimage.2012.03.072.

This list was generated on Sun Oct 19 08:14:42 2014 BST.